Version 1 of 66 (2001-01-18 to 2002-01-30) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
Corporation: |
HOFFMANN-LA ROCHE LIMITED
2455 MEADOWPINE BLVD. MISSISSAUGA, ON L5N 6L7 Canada |
Telephone number: | 905-542-5555 |
Fax number: | 905-542-7130 |
Responsible officer name and position during the period of this registration: | RONNIE MILLER, PRESIDENT AND CEO |
Description of activities: | PHARMACEUTICALS, VITAMINS & FINE CHEMICALS, DIAGNOSTICS, FLAVOURS AND FEED PRE-MIXES |
The client is a subsidiary of the following parent companies: |
F. HOFFMANN-LA ROCHE LIMITED
POSTFACH 4002 BASEL Switzerland |
Coalition | The corporation is not a member of a coalition. |
Subsidiary: | The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking. |
Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Health Canada (HC), Industry Canada |
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Meetings, Written communications, whether in hard copy or electronic format |
Subject Matter: Areas of Concern: | Health, Intellectual Property, International Relations |
Subject Matter: Particulars: | BILLS OR RESOLUTIONS RE: REVIEW OF DRUG PATENT LEGISLATION (FORMERLY BILL C-91) |